Impact of COVID-19 and Other Infectious Diseases on Operations and Business Performance
First written in FY2020. 7 of 20 entries say "Worsened", first in FY2021-Q2. Latest entry: FY2026.
Tokyo Kaikan moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2025: 4 of 13 companies on the "Worse" side.
10 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「In the event of an outbreak or spread of an infectious disease, including COVID-19, our policy is to continue operations after taking measures that prioritize the safety of customers and employees. However, if the authorities impose restrictions or issue requests for voluntary restraint on the company or throughout its market area, this may affect the company's results.」
The company continues to disclose the risk that regulations and requests for voluntary restraints related to infectious disease may affect earnings as a major risk. - FY2026-H1RestatedAnnual report
「During the interim accounting period, there were no material changes in the occurrence of major risks that management recognises as potentially having a material impact on the financial position, operating results or cash flows of the filing company, among the matters relating to the business and accounting situation described in this interim report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no significant changes in its major risks, including the impact of infectious disease on operations and earnings. - FY2025-H1RestatedAnnual report
「During the interim accounting period, there were no material changes in the occurrence of major risks that management recognises as potentially having a material impact on the financial position, operating results or cash flows of the filing company, among the matters relating to the business and accounting situation described in this interim report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no significant changes in its major risks, including the impact of infectious disease on operations and earnings. - FY2024SoftenedAnnual report
「During the fiscal year, the Japanese economy progressed on a recovery trend as socioeconomic activity normalized following the containment of COVID-19.」
The company describes the containment of infectious disease and the normalization of socioeconomic activity, and continues to state that the impact of infectious disease on operations and earnings is diminishing. - FY2024-Q3SoftenedAnnual report
「During the cumulative third quarter, the Japanese economy progressed on a recovery trend toward normalization, although prices continued to rise due to supply-side factors, as restrictions on socioeconomic activity caused by COVID-19 were lifted.」
The discussion has changed to state that restrictions on socioeconomic activity caused by infectious disease have been lifted and normalization is progressing, while the impact of infectious disease on operations and earnings is diminishing. - FY2024-Q2SoftenedAnnual report
「During the cumulative second quarter, the Japanese economy progressed on a recovery trend, with personal consumption recovering as socioeconomic activity moved toward full normalization following the classification of new COVID-19 infections as a Category 5 infectious disease.」
The company describes the move of COVID-19 to Category 5, the full normalization of socioeconomic activity and the recovery in personal consumption, while its discussion of the impact of infectious disease on operations and earnings is becoming less prominent. - FY2024-Q1SoftenedAnnual report
「The period progressed generally on a recovery trend, as COVID-19 was downgraded from Category 2-equivalent to Category 5, adding momentum to the improvement in consumer sentiment.」
The company states that the move to Category 5 has added momentum to the improvement in consumer sentiment and that the impact of infectious disease on socioeconomic activity and operations is diminishing. - FY2023SoftenedAnnual report
「As COVID-19 is to be downgraded from Category 2-equivalent to Category 5 effective 8 May, the impact of waves of infectious disease on socioeconomic activity is expected to diminish further.」
Although the company continues to disclose the risk of infectious disease itself, it indicates that the impact on socioeconomic activity is expected to diminish following the move to Category 5. - FY2023-Q3WorsenedAnnual report
「During the cumulative third quarter period, Japan's economy remained on a recovery trend as the movement of people recovered alongside a decline in the number of new COVID-19 cases. However, the outlook for an economic recovery continues to require close attention due to the ongoing waves of the infectious disease, the recent surge in resource prices and sharp foreign-exchange fluctuations.」
Although the flow of people has recovered, waves of the infectious disease continue, and the impact of the infectious disease on operations and the demand environment, as well as uncertainty over the outlook, persists. - FY2023-Q2MaterialisedAnnual report
「The outbreak of the seventh wave of the infectious disease during the second quarter accounting period, the recent surge in resource prices and sharp foreign-exchange fluctuations continue to make the outlook for an economic recovery one that requires close attention.」
The seventh wave of the infectious disease actually occurred, and the impact of the infectious disease on the operating and demand environment continued. - FY2023-Q1RestatedAnnual report
「There were no new major risks during the three months ended 30 June, and no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there has been no material change in the risk that restrictions and requests for voluntary restraint related to infectious diseases may affect earnings, which remains a major risk. - FY2022RestatedAnnual report
「In the event of an outbreak or spread of an infectious disease, including COVID-19, our policy is to continue operations after taking measures that prioritize the safety of customers and employees. However, if the authorities impose restrictions or issue requests for voluntary restraint on the company or throughout its market area, this may affect the company's results.」
The risk that restrictions and requests for voluntary restraint related to infectious diseases may affect earnings continues to be disclosed as a major risk. Operating restrictions and uncertainty over the outlook continued during the fiscal year due to states of emergency and other measures, as well as new variants. - FY2022-Q3WorsenedAnnual report
「Although the flow of people recovered after the state of emergency was lifted in October, the outlook remains uncertain due to the emergence of new variants.」
Although the flow of people recovered after the state of emergency was lifted, uncertainty over the future impact of the infectious disease on operations and earnings has continued due to the emergence of new variants. - FY2022-Q2WorsenedAnnual report
「Particularly in the food-service industry, activities have been severely restricted by requests for voluntary restraint aimed at reducing the flow of people, and the challenging operating environment continues.」
Operating restrictions caused by efforts to reduce the flow of people and requests for voluntary restraint continued as the infectious disease spread. Although revenue increased year on year, it remained insufficient to absorb fixed costs. - FY2022-Q1WorsenedAnnual report
「Under these circumstances, revenue increased by ¥1,490 million year on year to ¥1,969 million, partly because revenue in the same quarter of the previous year had fallen sharply as the main facility and sales offices were closed for 50 days under the state of emergency, and partly because the company applied a new accounting standard for revenue recognition from the current fiscal year. However, revenue remained insufficient to absorb fixed costs, resulting in an operating loss of ¥448 million, compared with an operating loss of ¥1,155 million in the same quarter of the previous year, an ordinary loss of ¥151 million, compared with an ordinary loss of ¥932 million, and a quarterly net loss of ¥120 million, compared with a quarterly net loss of ¥1,265 million.」
Revenue and losses improved compared with the low levels in the same quarter of the previous year, when temporary closures were in effect, but operating restrictions under the infectious disease continued, and revenue remained insufficient to absorb fixed costs. - FY2021WorsenedAnnual report
「Revenue for the fiscal year declined substantially to ¥4,034 million, down 64.9% year on year, due to the spread of COVID-19 and the closure of Hamamatsucho Tokyo Kaikan in connection with the redevelopment of the World Trade Center Building.」
The impact of the spread of COVID-19 became evident throughout the fiscal year, and the closure of Hamamatsucho Tokyo Kaikan also contributed to the 64.9% year-on-year decline in revenue. - FY2021-Q3WorsenedAnnual report
「During the cumulative third-quarter period, orders received and sales declined substantially. Orders received were ¥1,074 million, down 81.3% year on year, and the order backlog was ¥3,362 million, down 17.0% year on year. Sales were ¥3,118 million, down 66.3% year on year. The primary reasons for this decline are as described in “(1) Operating Results.”」
Orders received, the order backlog and sales declined substantially due to the impact of COVID-19. - FY2021-Q2WorsenedAnnual report
「Although revenue has been recovering since operations resumed, the impact of the COVID-19 pandemic remains significant. In the cumulative second-quarter period, revenue was ¥1,464 million, a substantial decline of 75.1% year on year, as the company was forced to accept a significant decrease in revenue.」
The impact of the infectious disease continued after operations resumed, and revenue declined 75.1% year on year. - FY2021-Q1MaterialisedAnnual report
「Following the government's declaration of a state of emergency, we temporarily closed the main facility and sales offices for approximately 50 days from 11 April.」
Following the government's declaration of a state of emergency in response to COVID-19, the main facility and sales offices were temporarily closed, materially affecting sales and profit or loss. - FY2020First statedAnnual report
「In the event of an outbreak or spread of an infectious disease, including COVID-19, our policy is to continue operations after taking measures that prioritize the safety of customers and employees. However, if the authorities impose restrictions or issue requests for voluntary restraint on the company or throughout its market area, this may affect the company's results.」
The outbreak and spread of infectious diseases, including COVID-19, and the impact of operating restrictions and requests for voluntary restraint from the authorities on operations and earnings are explicitly identified as new major risks. The text also states that an infectious disease issue arose in the fourth quarter and that new demand contracted.